Clinical Trial Update: Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS [NA]

View source ↗

Summary

A clinical study is evaluating an innovative CAR-T cell therapy that targets IL-1RAP in patients with high-risk myelodysplastic syndromes; the trial status is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• CAR-T IL-1RAP targeting therapy

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Myelodysplastic Syndrome | NA | Status: NOT_YET_RECRUITING